SHIRE PHARMA LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 JUNE 2024
Company registration number SC703821 (Scotland)
PAGES FOR FILING WITH REGISTRAR
SHIRE PHARMA LTD
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2
SHIRE PHARMA LTD
BALANCE SHEET
AS AT
30 JUNE 2024
30 June 2024
- 1 -
31 June 2024
31 July 2023
Notes
£
£
£
£
Current assets
Debtors
2
100
100
Net current assets
100
100
Capital and reserves
-
-
Called up share capital
100
100

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial period ended 30 June 2024 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 10 October 2024 and are signed on its behalf by:
Mr Sean Manson
Director
Company registration number SC703821 (Scotland)
SHIRE PHARMA LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 JUNE 2024
- 2 -
1
Accounting policies
Company information

Shire Pharma Ltd is a private company limited by shares incorporated in Scotland. The registered office is .

1.1
Reporting period

The accounting period has been shortened to 30 June 2024 from 31 July 2024 in preparation for when he company starts to trade.

1.2
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.3
Profit and loss account

The company has not traded during the period or the preceding financial period. During this time, the company received no income and incurred no expenditure and therefore no Profit and loss account is presented in these financial statements.

2
Debtors
2024
2023
Amounts falling due within one year:
£
£
Other debtors
100
100
2024-06-302023-08-01trueCCH SoftwareCCH Accounts Production 2024.200No description of principal activityMr Sean A G MansonMr U RazzaqfalsefalseSC7038212023-08-012024-06-30SC7038212024-06-30SC7038212023-07-31SC703821core:ShareCapital2024-06-30SC703821core:ShareCapital2023-07-31SC703821bus:Director12023-08-012024-06-30SC703821core:WithinOneYear2024-06-30SC703821core:WithinOneYear2023-07-31SC703821bus:EntityHasNeverTraded2023-08-012024-06-30SC703821bus:PrivateLimitedCompanyLtd2023-08-012024-06-30SC703821bus:SmallCompaniesRegimeForAccounts2023-08-012024-06-30SC703821bus:FRS1022023-08-012024-06-30SC703821bus:AuditExemptWithAccountantsReport2023-08-012024-06-30SC703821bus:Director22023-08-012024-06-30SC703821bus:FullAccounts2023-08-012024-06-30xbrli:purexbrli:sharesiso4217:GBP